After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
India is developing very fast in the field of technology. Today the situation is that India is be
Weather Update: Snowy winds made Delhi-NCR feel cold, IMD alerted about snowfall on mountains
Snowfall continues in the hilly areas. In such a situation, the effect of this snowfall is also s
Samsung: The company is soon bringing a flagship phone with 200MP camera sensor, Galaxy S23 Ultra
Samsung Galaxy S23 Ultra Camera: Tech company Samsung is preparing to launch its new smartphone G
In the two-day session of Congress on the banks of Sabarbati river in Ahmedabad, Gujarat, party p
Leader of Opposition in Lok Sabha Rahul Gandhi has reached America. He addressed a session of stu
ISRO INSAT-3DS Mission: The countdown for the launch of the meteorological satellite INSAT-3DS ha
India will start a two-day military exercise 'Sea Vigil 2022' from Tuesday along its 7516 km long
Filmmaker Karan Johar is in the news these days for his series Love Stories. Now Karan is launchi
The case of Raja Raghuvanshi's death in Shillong, Meghalaya remains in the headlines. Raja Raghuv
Speaker of Israeli Parliament Knesset Amir Ohana is in India on his four-day visit. Ohana on Tues
